首页> 外文期刊>Analytical chemistry >Same-Single-Cell Analysis for the Study of Drug Efflux Modulation of Multidrug Resistant Cells Using a Microfluidic Chip
【24h】

Same-Single-Cell Analysis for the Study of Drug Efflux Modulation of Multidrug Resistant Cells Using a Microfluidic Chip

机译:使用单细胞分析研究使用微流控芯片的多药耐药细胞的药物流出调节

获取原文
获取原文并翻译 | 示例
       

摘要

Since multidrug resistance(MDR)is a major cause of failure in cancer chemotherapy,we report a microfluidic approach combined with the same-single-cell analysis to investigate the modulation of MDR,manifested as the inhibition of drug efflux.A microfluidic chip that was capable of selecting and retaining a single multidrug-resistant cancer cell was used to investigate drug efflux inhibition in leukemia cell lines.Three advantages of the microfluidic-based same-single-cell analysis(dubbed as SASCA)method have been revealed.First,it readily detects the modulation of drug efflux of anticancer compounds(e.g.,daunorubicin)by MDR modulators(e.g.,verapamil)among cellular variations.Second,SASCA is able to compare the different cellular abilities in response to drug efflux modulation based on the drug transport kinetics of single cells.Third,SASCA requires only a small number of cells,which may be beneficial for investigating drug resistance in minor cell subpopulations(e.g.,cancer"stem"cells).
机译:由于多药耐药(MDR)是癌症化疗失败的主要原因,因此,我们报告了一种微流控方法,结合同一个单细胞分析来研究MDR的调节作用,以抑制药物外排为特征。能够选择并保留单个耐多药癌细胞的细胞用于研究白血病细胞系中的药物外排抑制作用。基于微流的相同单细胞分析(称为SASCA)方法的三个优点已被揭示。通过细胞变化中的MDR调节剂(例如维拉帕米),可以很容易地检测到抗癌化合物(例如柔红霉素)的药物流出调节。其次,SASCA能够根据药物转运动力学比较响应药物流出调节的不同细胞能力。第三,SASCA仅需要少量细胞,这对于研究次要细胞亚群(例如,癌症“干”细胞)中的耐药性可能是有益的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号